Company Research Report: Chemical Computing Group ULC (CCG)
Company Overview
- Name: Chemical Computing Group ULC
- Mission: CCG is a leading developer and provider of Molecular Modeling, Simulations, and Machine Learning software for pharmaceutical, biotechnology companies, and academic institutions worldwide. The company focuses on continuous development of new technologies through scientific collaborations and an internal team of mathematicians, scientists, and software engineers.
- Founded: No information is available
- Founder(s): No information is available
- Key People: No information is available
- Headquarters: 910-1010 Sherbrooke St. W., Montreal, QC H3A 2R7, Canada
- Number of Employees: No information is available
- Revenue: No information is available
- Notable Aspects:
- Known for its integrated Molecular Design Platform which supports small molecules, peptides, and biologics.
- Has been in industry leadership for over 30 years, providing standard platforms used extensively in pharmaceutical and biotechnology sectors.
Products
Integrated Molecular Design Platform
- Description: A sophisticated platform facilitating molecular design for small molecules, peptides, and biologics usable on laptops, clusters, cloud, and pipelines across multiple operating systems (Windows, Linux, Mac).
- Key Features:
- Built-in Programming Environment (SVL).
- 3D Molecular Visualization, Structure-Based Design, Antibody and Biologics Design, Fragment-Based Discovery.
- Comprehensive suites for ligand-based design, protein and peptide modeling, virtual screening, cheminformatics, and structural bioinformatics.
MOE (Molecular Operating Environment)
- Description: A software suite for computer-aided molecular design.
- Latest Version: MOE 2024.0601
- Key Features:
- 3D Molecular Visualization with GPU Acceleration.
- Interactive Database Viewer Property Filters.
- Support for enhanced molecular simulations like Induced-Fit Docking and Molecular Dynamics.
MOEsaic
- Description: A tool for Structure-Activity Relationship (SAR) visualization and analysis.
- Latest Version: MOEsaic 2024.0601
- Key Features:
- Identify and visualize chemical spaces.
- SAR and SPR visualization with integrated QSAR and QSPR models.
PSILO
- Description: Protein structure database and visualization system.
- Latest Version: PSILO 2024.06
- Key Features:
- Allows creation and maintenance of aligned RNA families.
- Annotates RNA structures with the RFAM Database.
Recent Developments
- New Product Releases:
- MOE 2024.0601: Released on October 29, 2024, featuring updated Amber EHT Forcefield Parameters, and support for non-natural RNA bases.
- MOEsaic 2024.0601: Released on October 29, 2024, with features focused on activity prediction using customized models.
- PSILO 2024.06: Released on September 16, 2024, adding features like Fourier Shell Correlation plots for CryoEM.
- New Features:
- Pharmacophore-guided High-throughput Biologics Virtual Screening.
- Support for calculating ECD and ORD spectra to determine stereochemistry.
- New web-based SAR Explorer for MOEsaic to enhance ligand exploration and profiling.
- Partnerships: No specific partnerships mentioned in the provided data.
- Conferences and Workshops:
- Hosting various UGMs and Conferences in North America and Europe in 2025 focusing on computational chemistry and molecular design.
- Hands-on workshops scheduled globally offering training in Computer-Aided Drug Design.
Contact Information
- General Enquiries: info@chemcomp.com
- Sales: sales@chemcomp.com
- Scientific Support: support@chemcomp.com
- Academic Inquiries: edu@chemcomp.com
- Far East Inquiries: ccg@molsis.co.jp
Conclusion
Chemical Computing Group ULC is positioned as a leader in molecular modeling and computational chemistry, providing an expansive suite of software products, continuous innovation, and robust support for global pharmaceutical and academic communities. The company’s commitment to scientific excellence is evident through its ongoing product development, training initiatives, and active engagement with the academic sector.
